Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
β-Casomorphin, human, 95+% REF: 02-J62271CAS: 102029-74-3 | 95+% | To inquire | Tue 03 Dec 24 | |
β-Casomorphin (human) REF: 01-4009611CAS: 102029-74-3 | 98.8% | 110.00 €~421.00 € | Tue 03 Dec 24 | |
b-Casomorphin, human REF: 3D-FC73316CAS: 102029-74-3 | Min. 95% | 194.00 €~986.00 € | Tue 21 Jan 25 | |
β-Casomorphin, human REF: TM-T7613CAS: 102029-74-3 | 99% | - - - | Discontinued product |
β-Casomorphin, human, 95+%
CAS:102029-74-3
An opioid peptide This Thermo Scientific Chemicals brand product was originally part of the Alfa …
Formula:
C44H61N7O11
Purity:
95+%
Molecular weight:
864.01
Ref: 02-J62271
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 3 Dec 2024
β-Casomorphin (human)
CAS:102029-74-3
Human β-Casomorphin-7, YPFVEPI, a bioactive peptide from milk, is also used as a model peptide …
Formula:
C44H61N7O11
Purity:
98.8%
Color and Shape:
White
Molecular weight:
864.01
Ref: 01-4009611
5mg | 110.00 € | ||
25mg | 421.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
b-Casomorphin, human
CAS:102029-74-3
Please enquire for more information about b-Casomorphin, human including the price, delivery time and more …
Formula:
C44H61N7O11
Purity:
Min. 95%
Molecular weight:
864 g/mol
Ref: 3D-FC73316
1mg | 194.00 € | ||
2mg | 310.00 € | ||
5mg | 436.00 € | ||
10mg | 647.00 € | ||
25mg | 986.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
β-Casomorphin, human
CAS:102029-74-3
β-Casomorphin, human (β-Casomorphin, human(TFA))(TFA) is an opioid receptor agonist.
Formula:
C44H61N7O11
Purity:
99%
Color and Shape:
Solid
Molecular weight:
864
Ref: TM-T7613
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
200mg | Discontinued | Request information |